Study Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic Treatment

Completed · Phase 2 · Has a placebo group

Conditions studied: Parkinson Disease

In brief

This study will evaluate the efficacy and safety of AKST4290 in subjects with Parkinson's Disease who are currently on stable dopaminergic treatment.

Key facts

Study ID
NCT04369430
Run by
Alkahest, Inc.
People needed
110
Starts
2020-01-16
Expected to finish
2021-03-10
Last updated by the study team
2022-10-10

Who can join

Age: 50 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.